Starpharma Holdings Limited (ASX:SPL)

Starpharma Holdings Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 17, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	293	37	39	127	302	607
Market Cap Growth	614.34%	-5.98%	-69.24%	-57.90%	-50.21%	44.84%
Enterprise Value	275	19	10	91	255	538
Last Close Price	0.69	0.09	0.10	0.31	0.74	1.50
PS Ratio	20.08	6.29	4.01	29.30	58.55	174.10
PB Ratio	13.63	1.94	1.39	3.66	6.25	9.74
P/TBV Ratio	13.63	1.94	1.39	3.66	6.25	9.74
EV/Sales Ratio	18.88	3.25	1.04	20.97	49.34	154.38
Debt / Equity Ratio	0.04	0.13	0.13	0.24	0.17	0.02
Net Debt / Equity Ratio	-0.81	-0.68	-0.70	-0.77	-0.86	-0.95
Net Debt / EBITDA Ratio	5.89	1.34	2.53	1.77	2.64	3.05
Net Debt / FCF Ratio	15.87	1.91	2.81	1.80	2.98	3.94
Asset Turnover	0.52	0.19	0.22	0.07	0.07	0.06
Inventory Turnover	4.95	4.43	4.13	4.42	6.36	14.33
Quick Ratio	4.86	3.76	4.46	3.00	5.65	6.61
Current Ratio	5.26	4.32	4.94	3.26	5.93	6.78
Return on Equity (ROE)	-14.47%	-42.41%	-25.95%	-37.59%	-29.19%	-42.15%
Return on Assets (ROA)	-7.24%	-20.06%	-11.48%	-16.53%	-14.48%	-21.96%
Return on Capital Employed (ROCE)	-15.00%	-49.50%	-27.10%	-41.60%	-28.90%	-31.40%
Earnings Yield	-1.10%	-27.14%	-20.86%	-12.29%	-5.34%	-3.25%
FCF Yield	-0.38%	-18.48%	-18.05%	-11.73%	-4.63%	-2.48%
Buyback Yield / Dilution	-1.07%	-1.40%	-0.59%	-0.53%	-2.53%	-6.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.